1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study

BACKGROUND: Patient-reported antibiotic allergies (so-called antibiotic allergy labels [AALs]) are found in one in four cancer patients and significantly impact patient outcomes. Whilst 85% of AALs can be removed by skin testing, the role of simple point-of-care oral penicillin rechallenge in this c...

Descripción completa

Detalles Bibliográficos
Autores principales: Smibert, Olivia, Douglas, Abby, Devchand, Misha, Lambros, Belinda, Stevenson, Wendy, Slavin, Monica, Trubiano, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253206/
http://dx.doi.org/10.1093/ofid/ofy210.1443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253206/
http://dx.doi.org/10.1093/ofid/ofy210.1443

Ejemplares similares